American International Group, Inc. Avalo Therapeutics, Inc. Transaction History

American International Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$3.0 - $10.45 $92,799 - $323,249	-30,933 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$7.57 - $21.72 $16,487 - $47,306	-2,178 Reduced 6.58%	30,933 $22,000
Q4 2021 Feb 11, 2022	BUY	$19.68 - $28.68 $81,278 - $118,448	4,130 Added 14.25%	33,111 $56,000
Q3 2021 Nov 12, 2021	BUY	$26.16 - $40.68 $758,142 - $1.18 Million	28,981 New	28,981 $63,000

34.6K

Ticker AVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,414,100
Market Cap $117M
Description
Avalo Therapeutics, Inc., a clinical-stage precision medicine company, discovers, develops, and commercializes targeted therapeutics for patients with unmet clinical need in immunology, immuno-oncology, and rare genetic diseases. It develops AVTX-002, a fully human anti-LIGHT monoclonal antibody, which is under Phase II clinical trial for the tr...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.